Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The measles virus H glycoprotein is an essential envelope protein responsible for attachment to host cells. It binds to cellular receptors such as SLAM/CD150, CD46, and Nectin-4, initiating the process of viral entry. The H protein is a major target for neutralizing antibodies and is highly conserved, making it a crucial component in the efficacy of measles vaccines. Mutations in the receptor binding site are strongly selected against due to impairing infectivity. Structural studies have revealed important details about its receptor-binding mechanism.
Binds to cellular receptors (SLAM/CD150, CD46, Nectin-4) to initiate viral entry.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Measles Virus Hemagglutinin Glycoprotein.